Sapient Capital LLC Buys Shares of 77,520 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sapient Capital LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 77,520 shares of the medical equipment provider’s stock, valued at approximately $26,152,000.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. OFI Invest Asset Management purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth about $25,000. Baystate Wealth Management LLC grew its position in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the last quarter. MCF Advisors LLC raised its stake in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares in the last quarter. Headinvest LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $28,000. Finally, Stone House Investment Management LLC boosted its stake in shares of Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, President David J. Rosa sold 80,710 shares of the company’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total value of $31,418,788.80. Following the transaction, the president now owns 163,399 shares in the company, valued at approximately $63,607,962.72. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares of the company’s stock, valued at $736,800. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, President David J. Rosa sold 80,710 shares of the company’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the sale, the president now directly owns 163,399 shares of the company’s stock, valued at approximately $63,607,962.72. The disclosure for this sale can be found here. Insiders sold 226,928 shares of company stock worth $87,833,828 over the last three months. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research note on Friday, January 19th. Barclays increased their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Royal Bank of Canada lifted their target price on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Finally, Piper Sandler increased their price target on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $3.71 during trading on Friday, hitting $381.36. The company’s stock had a trading volume of 1,028,858 shares, compared to its average volume of 1,492,254. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The company has a market capitalization of $135.27 billion, a PE ratio of 68.84, a P/E/G ratio of 4.93 and a beta of 1.39. The company has a fifty day simple moving average of $385.40 and a two-hundred day simple moving average of $349.30.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s revenue was up 11.5% on a year-over-year basis. During the same period last year, the business earned $1.00 earnings per share. As a group, analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.